These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19838499)

  • 21. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
    Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal medical therapy with or without PCI for stable coronary disease.
    Boden WE; O'Rourke RA; Teo KK; Hartigan PM; Maron DJ; Kostuk WJ; Knudtson M; Dada M; Casperson P; Harris CL; Chaitman BR; Shaw L; Gosselin G; Nawaz S; Title LM; Gau G; Blaustein AS; Booth DC; Bates ER; Spertus JA; Berman DS; Mancini GB; Weintraub WS;
    N Engl J Med; 2007 Apr; 356(15):1503-16. PubMed ID: 17387127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.
    Boden WE; O'rourke RA; Teo KK; Hartigan PM; Maron DJ; Kostuk W; Knudtson M; Dada M; Casperson P; Harris CL; Spertus JA; Shaw L; Chaitman BR; Mancini GB; Berman DS; Weintraub WS;
    Am Heart J; 2006 Jun; 151(6):1173-9. PubMed ID: 16781214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
    Zhang Z; Kolm P; Boden WE; Hartigan PM; Maron DJ; Spertus JA; O'Rourke RA; Shaw LJ; Sedlis SP; Mancini GB; Berman DS; Dada M; Teo KK; Weintraub WS
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):172-82. PubMed ID: 21304091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease.
    Rothberg MB; Sivalingam SK; Ashraf J; Visintainer P; Joelson J; Kleppel R; Vallurupalli N; Schweiger MJ
    Ann Intern Med; 2010 Sep; 153(5):307-13. PubMed ID: 20820040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery.
    Kapoor JR; Gienger AL; Ardehali R; Varghese R; Perez MV; Sundaram V; McDonald KM; Owens DK; Hlatky MA; Bravata DM
    JACC Cardiovasc Interv; 2008 Oct; 1(5):483-91. PubMed ID: 19463349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive medical management of coronary artery disease versus mechanical revascularization.
    Chiquette E; Chilton R
    Curr Atheroscler Rep; 2003 Mar; 5(2):118-23. PubMed ID: 12573197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina.
    Atwater BD; Oujiri J; Wolff MR
    Clin Cardiol; 2009 Aug; 32(8):E1-3. PubMed ID: 19536842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
    Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
    Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One year perspective on COURAGE.
    Tommaso CL
    Catheter Cardiovasc Interv; 2008 Sep; 72(3):426-429. PubMed ID: 18727125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study.
    Nishigaki K; Yamazaki T; Kitabatake A; Yamaguchi T; Kanmatsuse K; Kodama I; Takekoshi N; Tomoike H; Hori M; Matsuzaki M; Takeshita A; Shimbo T; Fujiwara H;
    JACC Cardiovasc Interv; 2008 Oct; 1(5):469-79. PubMed ID: 19463347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current medical management of chronic stable angina.
    Thadani U
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S11-29; quiz S98-9. PubMed ID: 15378129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New frontiers and unresolved controversies in percutaneous coronary intervention.
    Dzavik V
    Am J Cardiol; 2003 Feb; 91(3A):27A-33A. PubMed ID: 12645641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.
    Mehran R; Pocock S; Nikolsky E; Dangas GD; Clayton T; Claessen BE; Caixeta A; Feit F; Manoukian SV; White H; Bertrand M; Ohman EM; Parise H; Lansky AJ; Lincoff AM; Stone GW
    JACC Cardiovasc Interv; 2011 Jun; 4(6):654-64. PubMed ID: 21700252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Percutaneous coronary intervention in addition to optimal medical therapy for stabile coronary artery disease - a systematic review and meta-analysis].
    Gorenoi V; Hagen A
    Dtsch Med Wochenschr; 2014 May; 139(20):1039-45. PubMed ID: 24801298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Dagenais GR; Lu J; Faxon DP; Kent K; Lago RM; Lezama C; Hueb W; Weiss M; Slater J; Frye RL;
    Circulation; 2011 Apr; 123(14):1492-500. PubMed ID: 21444887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.
    Simoons ML; Windecker S
    Eur Heart J; 2010 Mar; 31(5):530-41. PubMed ID: 20106842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.
    Weintraub WS; Boden WE; Zhang Z; Kolm P; Zhang Z; Spertus JA; Hartigan P; Veledar E; Jurkovitz C; Bowen J; Maron DJ; O'Rourke R; Dada M; Teo KK; Goeree R; Barnett PG;
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):12-20. PubMed ID: 20031783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.